4-(4-methoxybenzylamino)-9,10-dioxo-9,10-dihydroanthracen-1-yl 4-methylbenzenesulfonate

ID: ALA2442835

PubChem CID: 72546227

Max Phase: Preclinical

Molecular Formula: C29H23NO6S

Molecular Weight: 513.57

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(CNc2ccc(OS(=O)(=O)c3ccc(C)cc3)c3c2C(=O)c2ccccc2C3=O)cc1

Standard InChI:  InChI=1S/C29H23NO6S/c1-18-7-13-21(14-8-18)37(33,34)36-25-16-15-24(30-17-19-9-11-20(35-2)12-10-19)26-27(25)29(32)23-6-4-3-5-22(23)28(26)31/h3-16,30H,17H2,1-2H3

Standard InChI Key:  VTZXTZLAVFOTEP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   22.0059   -1.6933    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   22.4124   -0.9764    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.5883   -0.9828    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7246   -3.3629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7235   -4.1893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4374   -4.6018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4357   -2.9506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1503   -3.3593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1537   -4.1914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8720   -4.6023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8653   -2.9380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5882   -3.3533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5912   -4.1852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3118   -4.5967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0301   -4.1777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0231   -3.3427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3019   -2.9349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8746   -5.4263    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.8607   -2.1139    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.2954   -2.1108    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.7228   -2.0997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7242   -2.9228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4402   -3.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1516   -2.9115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1424   -2.0832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4259   -1.6806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8690   -3.3170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3155   -5.4208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.0311   -5.8296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0349   -6.6536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3226   -7.0648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3260   -7.8880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0422   -8.2977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7563   -7.8779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7493   -7.0560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0470   -9.1218    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.3358   -9.5379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  1  3  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 10 13  1  0
 12 11  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 10 18  2  0
 11 19  2  0
 17 20  1  0
 20  1  1  0
  1 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 24 27  1  0
 14 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 30  1  0
 33 36  1  0
 36 37  1  0
M  END

Associated Targets(Human)

OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI/ADR-RES (33767 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BXPC-3 (2997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 513.57Molecular Weight (Monoisotopic): 513.1246AlogP: 5.16#Rotatable Bonds: 7
Polar Surface Area: 98.77Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 1.24CX LogP: 6.34CX LogD: 6.34
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.30Np Likeness Score: -0.50

References

1. Sangthong S, Ha H, Teerawattananon T, Ngamrojanavanich N, Neamati N, Muangsin N..  (2013)  Overcoming doxorubicin-resistance in the NCI/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives.,  23  (22): [PMID:24095089] [10.1016/j.bmcl.2013.09.004]

Source